| |
| |
|
| Insider
Information: |
Lawrence David |
| Relationship: |
Chief, Bus. Ops & PAO |
| City: |
Hawthorne |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
13,811 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,933 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
13,811 |
|
|
| Total
Value |
$6,933 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
Chief, Bus. Ops & PAO |
2020-12-01 |
13,811 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2013-10-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
25,030 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-02-23 |
4 |
AS |
$23.00 |
$139,433 |
D/D |
(5,941) |
25,131 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2011-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
26,145 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2012-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
27,249 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2018-06-07 |
4 |
OE |
$20.59 |
$409,329 |
D/D |
19,880 |
28,004 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-01-23 |
4 |
AS |
$17.37 |
$104,262 |
D/D |
(5,941) |
31,072 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2018-01-19 |
4 |
OE |
$19.81 |
$602,581 |
D/D |
30,418 |
35,111 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-12-20 |
4 |
AS |
$15.70 |
$94,019 |
D/D |
(5,941) |
37,013 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2014-12-18 |
4 |
OE |
$8.14 |
$220,667 |
D/D |
27,109 |
38,155 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-12-11 |
4 |
AS |
$16.91 |
$23,192 |
D/D |
(1,365) |
42,954 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-11-20 |
4 |
AS |
$17.76 |
$19,180 |
D/D |
(1,058) |
44,319 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-11-20 |
4 |
AS |
$18.97 |
$77,087 |
D/D |
(4,000) |
45,377 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-06-04 |
4 |
OE |
$2.60 |
$168,954 |
D/D |
30,890 |
45,506 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2015-12-18 |
4 |
OE |
$5.85 |
$230,931 |
D/D |
39,026 |
48,228 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-11-06 |
4 |
AS |
$15.97 |
$238,434 |
D/D |
(14,853) |
49,377 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial OfficerOfficer |
• – – |
2006-02-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
64,230 |
|
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2017-02-09 |
4 |
OE |
$22.13 |
$1,398,240 |
D/D |
63,183 |
67,719 |
0 |
- |
|
92 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
